CYTOSORBENTS CORP shareholders Q2 2023

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 58 filers reported holding CYTOSORBENTS CORP in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

CYTOSORBENTS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
CM Management, LLC 450,000$1,6161.58%
Skylands Capital, LLC 2,793,470$10,028,5571.44%
Sargent Investment Group, LLC 1,289,546$4,629,4701.12%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 237,940$854,2050.96%
Avenir Corp 2,719,732$9,763,8380.86%
Granahan Investment Management 1,616,587$5,803,5470.18%
Seelaus Asset Management LLC 20,450$730.06%
Cowen Prime Advisors LLC 42,301$151,8610.05%
HighMark Wealth Management LLC 10,000$35,9000.03%
Key Client Fiduciary Advisors, LLC 12,000$43,0800.02%
Eudaimonia Partners, LLC 23,500$84,3650.02%
Texas Capital Bank Wealth Management Services Inc 36,739$131,8930.01%
B.O.S.S. Retirement Advisors, LLC 13,491$48,4330.01%
Regal Investment Advisors LLC 19,168$68,8140.01%
HARBOR CAPITAL ADVISORS, INC. 6,482$23,2700.01%
Neuberger Berman Group LLC 1,488,645$5,344,2360.01%
COUNTRY CLUB BANK /GFN 15,225$54,6570.00%
Hexagon Capital Partners LLC 3,333$11,9650.00%
Chicago Partners Investment Group LLC 19,760$66,1960.00%
Houlihan Financial Resource Group, Ltd. 18,600$590.00%
External links

This page lists CYTOSORBENTS CORP's shareholders in Q2 2023. To view CYTOSORBENTS CORP's shareholder history, click here.